Zymeworks (ZYME) Common Equity (2021 - 2026)
Zymeworks' Common Equity came in at $80.37 million for Q2 2026, down 76.0% from $334.51 million a year earlier and down 50.9% from the prior quarter.
Analysis
Zymeworks (ZYME) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Zymeworks' Common Equity was $268.5 million, down 20.7% from FY2024.
- Common Equity has declined in each of the last three years, with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- Going back by year, Common Equity was $338.77 million in FY2024 (-27.1%), $464.81 million in FY2023 (-5.7%), $492.96 million in FY2022 (+97.9%) and $249.09 million in FY2021 (-39.2%).
- The Q2 2026 figure represents the lowest quarterly Common Equity in data going back to Q3 2021.
- Year-over-year, Common Equity has declined for 11 consecutive quarters, with an average decline of 30.4% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q3 2023 (growth of 136.1%), and the weakest in Q2 2026 (a decline of 76.0%).
- Business Quant data shows ZYME's Common Equity at $163.59 million (Q1 2026), $268.5 million (Q4 2025) and $320.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Zymeworks | 1.94 Bn | 820.54 Mn | - | 80.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.37 Mn |
| Mar 31, 2026 | 163.59 Mn |
| Dec 31, 2025 | 268.50 Mn |
| Sep 30, 2025 | 320.06 Mn |
| Jun 30, 2025 | 334.51 Mn |
| Mar 31, 2025 | 324.97 Mn |
| Dec 31, 2024 | 338.77 Mn |
| Sep 30, 2024 | 366.98 Mn |
| Jun 30, 2024 | 406.16 Mn |
| Mar 31, 2024 | 438.00 Mn |
| Dec 31, 2023 | 464.81 Mn |
| Sep 30, 2023 | 424.34 Mn |
| Jun 30, 2023 | 448.92 Mn |
| Mar 31, 2023 | 473.54 Mn |
| Dec 31, 2022 | 492.96 Mn |
| Sep 30, 2022 | 179.76 Mn |
| Jun 30, 2022 | 222.28 Mn |
| Mar 31, 2022 | 282.44 Mn |
| Dec 31, 2021 | 249.09 Mn |
| Sep 30, 2021 | 278.93 Mn |
API Access
Zymeworks Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ZYME&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();